14097-40-6

Basic information

• Product Name: 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine
• Synonyms: 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine;(2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amine;2-Methyl-1,2,3,4-tetrahydro-7-isoquinolinamine;7-AMino-1,2,3,4-tetrahydro-2-Methyl-7-Isoquinoline;1,2,3,4-tetrahydro-2-methyl-7-isoquinolinamine
• CAS NO: 14097-40-6
• Molecular Formula: C₁₀H₁₄N₂
• Molecular Weight: 162.23156
• Mol File: 14097-40-6.mol
• Article Data: 15

Chemical Properties

• Melting Point: 90-92℃
• Boiling Point: 291℃
• Flash Point: 113℃
• Appearance: /
• Density: 1.084
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.597
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 8.77±0.20(Predicted)
• CAS DataBase Reference: 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine(14097-40-6)
• EPA Substance Registry System: 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine(14097-40-6)

Safety Data

• Hazardous Substances Data: 14097-40-6(Hazardous Substances Data)

Usage

General Description

2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine, also known as 2-Methyltetrahydroisoquinoline-7-amine, is a chemical compound with the molecular formula C10H13N. It is a derivative of tetrahydroisoquinoline and contains a methyl group attached to the second carbon atom. 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine is a tertiary amine, meaning it contains a nitrogen atom bonded to three alkyl groups. 2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-aMine has been studied for its potential pharmacological properties, including its role in the central nervous system and as a potential drug target for neurological disorders. Furthermore, it may also have applications in organic synthesis and pharmaceutical research.

InChI:InChI=1/C10H14N2/c1-12-5-4-8-2-3-10(11)6-9(8)7-12/h2-3,6H,4-5,7,11H2,1H3

Upstream product

• 1612-65-3 2-methyl-1,2,3,4-tetrahydroisoquinoline 
• 14097-35-9 2-methyl-7-nitro-1,2,3,4-tetrahydroisoquinoline 
• 42923-79-5 7-nitro-1,2,3,4-tetrahydroisoquinoline 
• 24954-63-0 2,2,2-Trifluoro-N-(2-(4-nitrophenyl)ethyl)acetamide 
• 181514-37-4 2,2,2-trifluoro-1-(7-nitro-3,4-dihydroisoquinolin-2(1H)-yl)-ethan-1-one 
• 108130-11-6 1-(2-chloro-ethyl)-2-chloromethyl-4-nitro-benzene 
• 171049-41-5 tert-butyl 7-amino-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 99365-69-2 7-nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride 
• 91-21-4 1,2,3,4-tetrahydroisoquinoline 

Downstream Products

• 88493-58-7 1,2,3,4-tetrahydro-2-methylisoquinolin-7-ol 
• 84017-98-1 N-(2-methyl-1,2,3,4-tetrahydro-[7]isoquinolyl)-benzamide 
• 37481-34-8 3,4,5-trimethoxy-N-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-benzamide 
• 957469-50-0 (2R,4R)-4-methoxy-pyrrolidine-1,2-dicarboxylic acid-1-[(4-chloro-phenyl)-amide]-2-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide 
• 1126430-47-4 N-{4-[4-[3,5-bis(methyloxy)phenyl]-2-(cyclopropylamino)-1,3-thiazol-5-yl]-2-pyrimidinyl}-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinamine 
• 941318-79-2 N-[3-(4-fluoro-3-{2-[(2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl)amino]-4-pyrimidinyl}pyrazolo[1,5-a]pyridin-2-yl)phenyl]-2-(2-thienyl)acetamide 
• 941319-16-0 N-[2-Methoxy-5-(3-{2-[(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]pyrimidin-4-yl}pyrazolo[1,5-a]pyridin-2-yl)phenyl]-2-(2-thienyl)acetamide 
• 1092793-14-0 3-(2,6-dichlorophenyl)-7-[(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]pyrimido[4,5-d]pyrimidin-2,4(1H,3H)-dione 
• 1092793-15-1 3-(2,6-dichlorophenyl)-1-methyl-7-[(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]pyrimido[4,5-d]pyrimidin-2,4(1H,3H)-dione 

Relevant articles and documents

MACROCYCLIC COMPOUND SERVING AS WEE1 INHIBITOR AND APPLICATIONS THEREOF

Disclosed in the present invention are a macrocyclic compound serving as a Weel inhibitor, and applications thereof in the preparation of drugs for treating Weel-related diseases. The present invention specifically relates to a compound represented by for

BENZOTHIADIAZINE COMPOUNDS

The invention is directed to substituted benzothiadiazine derivatives. Specifically, the invention is directed to compounds according to Formula (I):wherein R, R1, R2, R3, R4 and R5 are as defined herein. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, autoimmune diseases, infections, atherosclerosis, and ischemia-reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION

Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula (I).